Literature DB >> 152116

Epidermolytic hereditary palmoplantar keratoderma. Report of a family and treatment with an oral aromatic retinoid.

P Fritsch, H Hönigsmann, E Jaschke.   

Abstract

This study describes a family of 30 people in which 14 members have hereditary epidermolytic palmoplantar keratoderma. Four patients were treated with an oral aromatic retinoid for up to 5 months. They responded in a uniform and dramatic way: 10-14 days after the onset of therapy, the hyperkeratotic horny layer was sequestered in large sheets resulting in normal appearing skin and restoration of normal surface sensitivity. Biopsies revealed that the underlying disorder of keratinization had remained unchanged. Treatment with the retinoid had to be discontinued as the sensitivity and vulnerability restricted normal function of hands and feet.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 152116     DOI: 10.1111/j.1365-2133.1978.tb02025.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  Composite keratohyaline granules in palmoplantar keratoderma: an ultrastructural study.

Authors:  R Laurent; O Prost; M Nicollier; S C Marquet; M M Balzer; G Adessi
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  Autosomal recessive epidermolytic palmoplantar keratoderma.

Authors:  Q A Alsaleh; A S Teebi
Journal:  J Med Genet       Date:  1990-08       Impact factor: 6.318

3.  Systemic retinoids in the management of ichthyoses and related skin types.

Authors:  John J Digiovanna; Theodora Mauro; Leonard M Milstone; Matthias Schmuth; Jorge R Toro
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

Review 4.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.